Trial
NCT02179359
Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Sickle Cell Disease
Intervention
Reduced Toxicity Ablative Regimen
Why stopped
Replaced by another study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-03